Skip to Content

LU Q42 (Fenofibric Acid Delayed-Release 135 mg)

Pill with imprint LU Q42 is Blue & Yellow, Capsule-shape and has been identified as Fenofibric acid delayed-release 135 mg. It is supplied by Lupin Pharmaceuticals, Inc..

Fenofibric acid is used in the treatment of high cholesterol; hypertriglyceridemia and belongs to the drug class fibric acid derivatives. Risk cannot be ruled out during pregnancy. Fenofibric acid 135 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for LU Q42

Fenofibric acid delayed-release

LU Q42
135 mg
Blue & Yellow
Prescription only
Drug Class:
Fibric acid derivatives
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Lupin Pharmaceuticals, Inc.
National Drug Code (NDC):

Get help with Imprint Code FAQs.

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2018, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.